Partnership with 2bind GmbH
November 7, 2019
We welcome Chris to PharmAI
April 9, 2020

Agreement with

pharmAI and sign a collaboration agreement.

Gero LLC, an AI-powered platform and a drug pipeline for drug discovery and drug repurposing focused on complex diseases and chronic age-related diseases, has signed an agreement to utilize pharmAI’s services to analyze protein-protein interaction along the line of its drug development services.

This is an exciting project, opening new opportunities, exploring the power and flexibility of pharmAI’s discovery engine. We look forward to a successful collaboration.